▶ Video 1: Heart failure pathophysiology

Find out more about the pathophysiology of heart failure through this bitesize learning video, one in a series on the condition.

This independent video learning series on heart failure is funded by the Boehringer Ingelheim and Lilly Alliance. The BI Lilly Alliance had no influence over the content.

Summary: This bitesize learning video will cover the pathophysiology of heart failure for general nurses, defining heart failure, its main types, incidence and prevalence, and symptoms.

Presenter: Louise Clayton, advanced nurse practitioner and heart failure hospital service lead, University Hospitals of Leicester NHS Trust.

The video will seek to answer the following questions:
• What is heart failure? An overview of the condition: eg that the heart is unable to pump blood around the body properly
• What is heart failure with reduced ejection fraction (HFrEF) and what is heart failure with preserved ejection fraction (HFpEF), and what are the key differences?
• What is the incidence and prevalence of heart failure in the UK, including any regional differences? Are there differences in incidence and prevalence between HFrEF and HFpEF?
• What are the main symptoms of heart failure? For example, breathlessness after activity; feeling tired most of the time; feeling lightheaded or fainting; swollen ankles and legs; plus less common symptoms

The full series:

Visit the Nursing Times clinical zone on cardiovascular disease

This independent video learning series on heart failure is funded by the Boehringer Ingelheim and Lilly Alliance. The BI Lilly Alliance had no influence over the content, selection of presenter or editorial control.

References:

• Conrad N (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. The Lancet; 391: 10120, 572–580.
• Hartupee J (2017) Neurohormonal activation in heart failure with reduced ejection fraction. Nature Reviews Cardiology; 14: 1, 30-38.
• McDonagh T (2021) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal; 42: 36, 3599-3726.
• National Health Service. Overview: heart failure.
• National Institute for Cardiovascular Outcomes (2017) National Heart Failure Audit: April 2015-March 2016. NIFOR.
• Nishikimi T (2006) The role of natriuretic peptides in cardioprotection. Cardiovascular Research; 69: 2, 318-328.
• Ponikowski P (2016) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal; 37: 27, 2129-2200.
• Volpe M (2016) The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment. Clinical Science (London); 130: 57-77.

Resources:

• British Society of Heart Failure
• Pumping Marvellous: The heart failure charity
• British Heart Foundation
• Cardiomyopathy UK